Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

http://scihub22266oqcxt.onion/ 32395790!ä!32395790 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Tunis+Med 2020 ; 98 (4): 283-294 Nephropedia Template TP {{tp|p=32395790|t=2020. COVID-19 and Cardiovascular diseases Scoping review study |pdf=|usr=}}{{32395790}} gab.com Text COVID-19 and Cardiovascular diseases Scoping review study JO: Tunis Med http://www.kidney.de/pget.php?&tw=1&pmid=32395790 #FOAvip BACKGROUND: Many patients with COVID-19 have pre-existing cardiovascular (CV) co-morbidities or develop acute heart damage during the course of the disease. OBJECTIVES: To study the risk of COVID-19 infection in the presence of preexisting CV diseases and to describe new CV manifestations during COVID-19. METHODS: A "scoping review" was carried out via PubMed, to synthesize the results of research currently published on this subject. RESULTS: Patients with cardiovascular disease were at greater risk of developing COVID-19, especially in its severe form. These patients were five to ten times more at risk of death. Cardiac manifestations, de novo, were dominated by acute myocardial damage, defined by a significant elevation of cardiac troponins. These occurred in 7 to 17% of hospitalized patients. The presence of a new heart lesion in patients with COVID-19 was consistently associated with a poor prognosis. CONCLUSION: Given the enormous cardiovascular challenge posed by the COVID-19 pandemic and the prognostic impact of heart damage, additional research at a high level of evidence will be necessary. Twit Text FOAVip COVID-19 and Cardiovascular diseases Scoping review study ????Tunis Med http://www.kidney.de/pget.php?&tw=1&pmid=32395790 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32395790 #FOAvip English Wikipedia <ref>{{Cite pmid|32395790}}</ref> COVID-19 and Cardiovascular diseases Scoping review study #MMPMID32395790 Yahia F; Zakhama L; Ben Abdelaziz A Tunis Med 2020[Apr]; 98 (4): 283-294 PMID32395790show ga BACKGROUND: Many patients with COVID-19 have pre-existing cardiovascular (CV) co-morbidities or develop acute heart damage during the course of the disease. OBJECTIVES: To study the risk of COVID-19 infection in the presence of preexisting CV diseases and to describe new CV manifestations during COVID-19. METHODS: A "scoping review" was carried out via PubMed, to synthesize the results of research currently published on this subject. RESULTS: Patients with cardiovascular disease were at greater risk of developing COVID-19, especially in its severe form. These patients were five to ten times more at risk of death. Cardiac manifestations, de novo, were dominated by acute myocardial damage, defined by a significant elevation of cardiac troponins. These occurred in 7 to 17% of hospitalized patients. The presence of a new heart lesion in patients with COVID-19 was consistently associated with a poor prognosis. CONCLUSION: Given the enormous cardiovascular challenge posed by the COVID-19 pandemic and the prognostic impact of heart damage, additional research at a high level of evidence will be necessary. |Betacoronavirus[MESH] |COVID-19[MESH] |Cardiovascular Diseases/*epidemiology[MESH] |Comorbidity[MESH] |Coronavirus Infections/*epidemiology[MESH] |Humans[MESH] |Pandemics[MESH] |Pneumonia, Viral/*epidemiology[MESH] |Prognosis[MESH]COVID-19 and Cardiovascular diseases Scoping review study (epmc).pdf DeepDyve Pubget Overpricing